XM bietet keine Dienstleistungen für Personen mit Wohnsitz in den Vereinigten Staaten von Amerika an.

XM bietet keine Dienstleistungen für Personen mit Wohnsitz in den Vereinigten Staaten von Amerika an.
A
A

Abbott

Nachrichten

Reuters - vor 6 Tagen

Diagnostics firm Labcorp weighs ramping up mpox testing capacity

UPDATE 2-Diagnostics firm Labcorp weighs ramping up mpox testing capacity Adds details on other tests from paragraph 6 By Sneha S K Aug 26 (Reuters) - Diagnostics firm Labcorp LH.N said it is working with U.S. health regulators to determine if it needed to ramp up its mpox testing capacity, as countries outside Africa detect a new type of the virus for the first time.
A
L
Reuters - vor 6 Tagen

Dexcom launches over-the-counter continuous glucose sensors in the US

UPDATE 2-Dexcom launches over-the-counter continuous glucose sensors in the US Adds pricing details in paragraphs 3, background throughout Aug 26 (Reuters) - Dexcom DXCM.O said on Monday its over-the-counter continuous glucose monitor, Stelo, is now available for use in the United States at a price of up to $99. S telo was cleared by the U.S. health regulator in March for use by adults aged 18 and older who do not use insulin, making it the the first continuous glucose monitor available for over
A
Reuters - vor 1 Woche

Stifel raises PT on Dexcom on positive physician sentiment for its devices

BUZZ-Stifel raises PT on Dexcom on positive physician sentiment for its devices ** Brokerage Stifel raises PT on glucose monitor maker Dexcom DXCM.O to $100 from $90 ** Shares of Dexcom were up 1.2% at $73.16 ** Says while work is needed to optimize the sales force/repair distributor relationships, physician sentiment on DXCM remains positive ** Co
A
S
Reuters - vor 1 Woche

U.S. Aadi Bioscience, Target, Visteon

U.S. RESEARCH ROUNDUP-Aadi Bioscience, Target, Visteon Aug 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aadi Bioscience, Target and Visteon, on Thursday. HIGHLIGHTS * Aadi Bioscience Inc AADI.O : Jefferies cuts to hold from buy * Assurant Inc AIZ.N : Piper Sandler cuts to neutral from overweight * Estée Lauder EL.N : Piper Sandler raises to overweight from neutral * Target Corp TGT.N : Jefferies raises target
A
A
H
S
T
T
U
A
P
U
D
E
A
Reuters - vor 1 Woche

Abbott Says FDA Approved Change To Label For Heartmate 3 Heart Pump

BRIEF-Abbott Says FDA Approved Change To Label For Heartmate 3 Heart Pump Aug 21 (Reuters) - Abbott Laboratories ABT.N : ABBOTT: FDA APPROVED CHANGE TO LABEL FOR HEARTMATE 3 HEART PUMP ABBOTT: ADVANCES HEART FAILURE MANAGEMENT WITH ASPIRIN FREE REGIMEN FOR PATIENTS RECEIVING THE HEARTMATE 3 HEART PUMP Source text for Eikon: [ID:] Further company co
A
Reuters - vor 2 Wochen

Medtronic nudges profit forecast on medical devices demand, new launches

UPDATE 3-Medtronic nudges profit forecast on medical devices demand, new launches Adds shares in paragraph 1, company comments from conference call in paragraphs 7,8, 10 and 13, analyst comment in paragraph 11, graphic By Sriparna Roy and Puyaan Singh Aug 20 (Reuters) - Medtronic MDT.N slightly lifted the lower end of its annual profit forecast on Tuesday, banking on sustained demand for its medical devices and growth from its new launches, sending its shares up 1.6% .
A
Reuters - vor 2 Wochen

Harris' anti-price gouging plan could build on US state law

EXPLAINER-Harris' anti-price gouging plan could build on US state law By Jody Godoy Aug 16 (Reuters) - As Vice President Kamala Harris focuses on price gouging in her presidential campaign, state laws and laws proposed by her colleagues in the Senate show potential paths for a crackdown on high prices. The Democratic candidate planned to lay out her anti-price gouging and other economic proposals in a speech in Raleigh, North Carolina, on Friday.
A
K
W
Reuters - vor 3 Wochen

Abbott India gains on upbeat Q1 results

BUZZ-Abbott India gains on upbeat Q1 results ** Shares of Abbott India ABOT.NS climb ~4% to 29,139.30 rupees, their highest since February ** Drugmaker reports 13% Y/Y rise in Q1 consol net profit ; 5.3% Y/Y rev growth ** Stock top pct gainer in pharma index .NIPHARM , which is up ~1% ** Trading volume 2.4x the 30-day moving average ** ABOT among 1
A
Reuters - vor 3 Wochen

India economic, corporate events on August 8

DIARY- India economic, corporate events on August 8 BENGALURU, Aug 8 (Reuters) - Diary of India economic, corporate events on August 8. ECONOMIC, CORPORATE .BSE500 EVENTS: RIC Local Start Date Local Time Indicator Name Period Reuters Poll Prior INREPO=ECI 8 Aug 2024 10:00 Repo Rate 8 Aug 6.50% 6.50% INRREP=ECI 8 Aug 2024 10:00 Reverse Repo Rate 8 A
A
A
A
B
B
Reuters - vor 3 Wochen

U.S. STOCKS Abbott Laboratories, Medtronic, Axon

BUZZ-U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes advanced on Wednesday, aided by a dovish turn by Japan's top policymaker after a surprise interest rate hike last week which partly sparked heavy volatility in global markets.
A
A
C
F
I
T
U
U
L
Reuters - vor 3 Wochen

Some diabetes device makers fall after Abbott, Medtronic glucose monitoring partnership

BUZZ-Some diabetes device makers fall after Abbott, Medtronic glucose monitoring partnership ** Shares of Tandem diabetes care TNDM.O fall ~9.9% to $39.17 ** Medical device makers Abbott Laboratories ABT.N and Medtronic MDT.N have entered into a partnership to integrate the former's continuous glucose monitoring (CGM) sensors with MDT's insulin del
A
C
Reuters - vor 3 Wochen

Abbott, Medtronic rise on glucose monitoring partnership

BUZZ-Abbott, Medtronic rise on glucose monitoring partnership Updates ** Shares of medical device makers Abbott Laboratories ABT.N rise 1.7% to $111.36 and Medtronic MDT.N r ise 1.8% to $82 .24 ** ABT says it has entered into a global partnership with MDT to integrate the former's continuous glucose monitoring (CGM) sensors with MDT's insulin deliv
A
Reuters - vor 3 Wochen

Abbott, Medtronic rise on glucose monitoring partnership

BUZZ-Abbott, Medtronic rise on glucose monitoring partnership ** Shares of medical device makers Abbott Laboratories ABT.N and Medtronic MDT.N rise 2.3% to $112.03 and $82.64, respectively ** ABT says it has entered into a global partnership with MDT to integrate the former's continuous glucose monitoring (CGM) sensors with MDT's insulin delivery s
A
Reuters - vor 3 Wochen

Drugmaker Abbott India's Q1 profit climbs on higher sales, price hikes

Drugmaker Abbott India's Q1 profit climbs on higher sales, price hikes BENGALURU, Aug 7 (Reuters) - Drugmaker Abbott India ABOT.NS reported a rise in first-quarter profit on Wednesday, helped by higher sales and price hikes. The company, which makes the popular antacid medicine Digene, said its profit rose to 3.28 billion rupees ($39.1 million) for the quarter ended June 30, a 13% rise from last year.
A
G
P
Reuters - vor 4 Wochen

India economic, corporate events on August 7

DIARY- India economic, corporate events on August 7 BENGALURU, Aug 7 (Reuters) - Diary of India economic, corporate events on August 7. ECONOMIC, CORPORATE .BSE500 EVENTS: Key Speaker Local Time Location India commerce minister 0930 BIMSTEC Business Summit, New Delhi India financial services secretary 1000 Industry body FICCI event, New Delhi RIC Local Start Date Local Time Indicator Name Period Reuters Poll Prior INM3MS=ECI 7 Aug 2024 17:00 M3 Money Supply 26 Jul, w/e 10.7% Start Date Start Tim
A
B
C
Reuters - vor 4 Wochen

India's GlaxoSmithKline Pharma posts higher Q1 adjusted profit on strong demand

India's GlaxoSmithKline Pharma posts higher Q1 adjusted profit on strong demand BENGALURU, Aug 2 (Reuters) - India's GlaxoSmithKline Pharmaceuticals GLAX.NS reported a higher first-quarter adjusted profit on Friday, driven by strong demand for its generic drugs and vaccines. The Indian unit of British drugmaker GSK GSK.L reported a consolidated profit before tax and exceptional items of 2.49 billion rupees ($29.7 million) for the quarter ended June 30, compared with a profit of 1.64 billion rupe
A
G
P
Reuters - vor 4 Wochen

Becton Dickinson tops profit estimates on demand for drug-delivery devices

Becton Dickinson tops profit estimates on demand for drug-delivery devices Aug 1 (Reuters) - Becton Dickinson BDX.N reported a better-than-expected third -quarter profit on Thursday , helped by strong demand for its drug-delivery devices. Medical technology firms such as Becton, Boston Scientific BSX.N and Abbott Laboratories ABT.N are benefiting from a boost in demand as more people, especially older patients, catch up on surgeries that were put on hold during the pandemic.
A
B
Reuters - vor 1 Monat

S&P 500 barely rises as investors await key results, jobs data, Fed meeting

US STOCKS-S&P 500 barely rises as investors await key results, jobs data, Fed meeting Tesla rallies after Morgan Stanley adds stock to 'top pick' list McDonald's rises on strong up-take of $5-meal deal Crypto stocks reverse earlier gains Indexes: Dow off 0.12%, S&P up 0.08%, Nasdaq up 0.07% Updates with closing prices, data By Sinéad Carew and Ankika Biswas July 29 (Reuters) - The S&P 500 c losed barely higher after Monday's choppy trading session as investors h eld their breath ahead of a raft
A
A
A
M
T
U
U
U
Reuters - vor 1 Monat

S&P 500 rises slightly ahead of key results, data, Fed meeting

US STOCKS-S&P 500 rises slightly ahead of key results, data, Fed meeting Adds preliminary closing prices at 4 p.m ET/ 2000 GMT By Sinéad Carew and Ankika Biswas July 29 (Reuters) - The S&P 500 c losed up slightly after Monday's choppy trading as investors anxiously awaited a raft of technology company earnings, a Federal Reserve policy decision on interest-rate cuts and key US labor data, all due this week.
A
A
A
M
T
U
U
U
Reuters - vor 1 Monat

U.S. indexes up in choppy session ahead of key results and data, Fed meeting

US STOCKS-U.S. indexes up in choppy session ahead of key results and data, Fed meeting Tesla up after Morgan Stanley adds stock to 'top pick' list McDonald's jumps on $5-meal deal beat Crypto stocks fall, Abbott drops after formula verdict Indexes: Dow off 0.02%, S&P up 0.15%, Nasdaq up 0.15% Updated prices at 2:29 p.m ET/ 1829 GMT By Sinéad Carew and Ankika Biswas July 29 (Reuters) - The Nasdaq and S&P 500 edged higher on Monday in choppy trading as investors anxiously awaited a raft of techno
A
A
A
M
T
U
U
U

Konditionen

Beliebte Finanzwerte

Rechtlicher Hinweis: Die Unternehmen der XM Group bieten Dienstleistungen ausschließlich zur Ausführung an sowie Zugang zu unserer Online-Handelsplattform. Durch diese können Personen die verfügbaren Inhalte auf oder über die Internetseite betrachten und/oder nutzen. Eine Änderung oder Erweiterung dieser Regelung ist nicht vorgesehen und findet nicht statt. Der Zugang wird stets geregelt durch folgende Vorschriften: (i) Allgemeine Geschäftsbedingungen; (ii) Risikowarnungen und (iii) Vollständiger rechtlicher Hinweis. Die bereitgestellten Inhalte sind somit lediglich als allgemeine Informationen zu verstehen. Bitte beachten Sie, dass die Inhalte auf unserer Online-Handelsplattform keine Aufforderung und kein Angebot zum Abschluss von Transaktionen auf den Finanzmärkten darstellen. Der Handel auf Finanzmärkten birgt ein hohes Risiko für Ihr eingesetztes Kapital.

Sämtliche Materialien, die auf unserer Online-Handelsplattform veröffentlicht sind, dienen ausschließlich dem Zweck der Weiterbildung und Information. Die Materialien beinhalten keine Beratung und Empfehlung im Hinblick auf Finanzen, Anlagesteuer oder Handel und sollten nicht als eine dahingehende Beratung und Empfehlung aufgefasst werden. Zudem enthalten die Materialien keine Aufzeichnungen unserer Handelspreise sowie kein Angebot und keine Aufforderung für jegliche Transaktionen mit Finanzinstrumenten oder unverlangte Werbemaßnahmen für Sie zum Thema Finanzen. Die Materialien sollten auch nicht dahingehend aufgefasst werden.

Alle Inhalte von Dritten und die von XM bereitgestellten Inhalte sowie die auf dieser Internetseite zur Verfügung gestellten Meinungen, Nachrichten, Forschungsergebnisse, Analysen, Kurse, sonstigen Informationen oder Links zu Seiten von Dritten werden ohne Gewähr bereitgestellt. Sie sind als allgemeine Kommentare zum Marktgeschehen zu verstehen und stellen keine Anlageberatung dar. Soweit ein Inhalt als Anlageforschung aufgefasst wird, müssen Sie beachten und akzeptieren, dass der Inhalt nicht in Übereinstimmung mit gesetzlichen Bestimmungen zur Förderung der Unabhängigkeit der Anlageforschung erstellt wurde. Somit ist der Inhalt als Werbemitteilung unter Beachtung der geltenden Gesetze und Vorschriften anzusehen. Bitte stellen Sie sicher, dass Sie unseren Hinweis auf die nicht unabhängige Anlageforschung und die Risikowarnung im Hinblick auf die vorstehenden Informationen gelesen und zur Kenntnis genommen haben, die Sie hier finden.

Risikowarnung: Es bestehen Risiken für Ihr eingesetztes Kapital. Gehebelte Produkte sind nicht für alle Anleger geeignet. Bitte beachten Sie unseren Risikohinweis.